Federated Hermes (FHI)
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
$62.40+0.39%
Close 2026-09-04 · 1-day change
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
QuarterlyIQ Insights · FHI
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $62 FHI trades at 12× p/e, below its 16× p/e peer median, but our blended $57 fair value sits below the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $57–$65. Note: our $57 fair value sits below the entire analyst range ($57–$65). Even valued only for durable growth at sustainable margins, it's worth about $68 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $58.50 | — | — | Analyst | high |
| ddm gordon | 12M | $24.03 | — | — | TTM | high |
| graham number | 12M | $45.91 | — | — | TTM | high |
| Peer P/B | 12M | $33.63 | 1.9 | 17.41 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$57.00 – $65.00 (median $58.50) · 4 analysts · as of 2026-08-10
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $75.21 |
| 13.0 |
| 5.80 |
| ntm analyst |
| high |
| Peer P/S | 12M | $87.27 | 3.2 | 26.88 | TTM | high |
| PEG | 12M | $68.57 | 12.7 | 5.38 | TTM | high |
| residual income | 12M | $32.60 | — | — | TTM | high |
| Own P/E history | 12M | $59.96 | 11.1 | 5.38 | TTM | high |
| triangulated | 12M | $91.39 | 16.3 | 5.59 | Triangulated | high |
| Peer P/B | 3Y | $37.15 | 1.9 | 19.24 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $84.17 | 13.0 | 6.49 | Analyst | medium |
| Peer P/S | 3Y | $103.00 | 3.2 | 31.73 | Analyst | medium |
| PEG | 3Y | $82.69 | 12.7 | 6.49 | Analyst | medium |
| Own P/E history | 3Y | $72.30 | 11.1 | 6.49 | Analyst | medium |
| Peer P/B | 5Y | $39.71 | 1.9 | 20.56 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $93.77 | 13.0 | 7.23 | Analyst | high |
| Peer P/S | 5Y | $114.75 | 3.2 | 35.34 | Analyst | high |
| PEG | 5Y | $92.12 | 12.7 | 7.23 | Analyst | high |
| Own P/E history | 5Y | $80.55 | 11.1 | 7.23 | Analyst | high |